FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Global approvals · expansion Widening hospital prescriptions in Korea while completing trial enrolment in Germany for local listing. Also seen: Commercial · sales

  • Completed enrolment of 82 patients in a German trial and began the local digital-therapeutic listing process. Source

Roles often seen at this stageClinical & PV · Regulatory affairs · Data & AI

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

WELT

The maker of the SleepQ insomnia digital therapeutic, supplied to Korean hospitals with a pharmaceutical partner and in a clinical trial in Germany.

SleepQ

Approved

Prescription digital therapeutic delivering cognitive behavioural therapy for insomnia by smartphone app, listed at about 20 general hospitals and more than 60 clinics.

Completion reported

Completed enrolment of 82 patients in its German trial.

Official role guide

WELT careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 2

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 한독·웰트 '슬립큐', 독일 임상 82명 환자 등록 완료... DiGA 등재 착수 ↗팜뉴스 · Published 2026-09-07 · Sources checked 2026-11-15 · Original unavailable
  2. 한독·웰트 "불면증 디지털 치료기기 '슬립큐' 상용 시장 확대" ↗네이트 뉴스 · Published 2026-03-10 · Sources checked 2026-11-15 · Original unavailable